Alcohol Use in HIV/AIDS: Compounded Immune Suppression and Infection Risk
Mechanistic Synergy
- HIV depletes CD4+ T cells → impaired cellular immunity.
- Alcohol suppresses:
- Neutrophil chemotaxis/phagocytosis
- Macrophage TNF-α, IL-1 production
- NK cell cytotoxicity
- Dendritic cell antigen presentation
- Mucosal barrier integrity (gut → microbial translocation → systemic LPS → chronic immune activation)
Clinical Consequences
- Opportunistic Infections: PJP, TB, MAC, cryptococcal meningitis, CMV — higher incidence, atypical presentation, worse outcomes.
- ART Adherence: Alcohol → missed doses → resistance → virologic failure.
- Liver Disease: HCV/HBV coinfection + alcohol + ART hepatotoxicity → accelerated fibrosis.
- Cancer: HPV-related (anal, cervical, oropharyngeal) — alcohol + immune dysfunction = persistence/progression.
Guidance
Abstinence ideal. If not achievable, harm reduction: <14 drinks/week (men), <7 (women); screen AUDIT-C; treat AUD (naltrexone, acamprosate, gabapentin) within HIV care.
HIV & AIDS - Related Articles
- HIV Transmission Outside Healthcare: Routes, Risks, and Prevention Pillars
- Understanding the Link Between HIV and Pain: A Pathophysiological Overview
- HIV Transmission: Routes, Risk Factors, and Prevention for All Genders
- Understanding HIV Test Results: Positive vs. Negative - A Clear Explanation
- Understanding HIV/AIDS Treatment Duration & Initiation
- HIV Symptoms: Timeline & Stages of Infection
- Understanding HIV for Children: Clear Explanations & Facts
